• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非一家三级医疗中心 redo 二尖瓣置换术的经验。

A South Africa tertiary centre experience with redo mitral valve replacement.

机构信息

Department of General Surgery, University of KwaZulu-Natal, South Africa.

Department of Cardiothoracic Surgery, University of KwaZulu-Natal, South Africa.

出版信息

S Afr J Surg. 2022 Mar;60(1):44-48.

PMID:35451269
Abstract

BACKGROUND

Severe cardiac failure from mechanical mitral valve thrombosis due to poor warfarin control is a major cause of emergency redo mitral valve replacement (MVR) in South Africa. This study aimed to review the outcomes of redo MVR in patients presenting with mitral valve failure to a tertiary South African centre.

METHODS

Retrospective chart review of patients undergoing redo MVR over a 10-year period (2005-2014). Patient demographics, aetiology of valve dysfunction, preoperative clinical assessment and outcomes were analysed.

RESULTS

Sixty-four patients had 80 mitral valve procedures. The M:F ratio was 1:2.8 and the median age was 18 (IQR 14-28.5) and 25 (IQR 18-40) at initial surgery and at redo surgery, respectively. Median interval between original and redo MVRs was 47.5 (IQR 7.5-124) months. Rheumatic valve disease was the original pathology in 58 patients (90.6%). Fifty-two patients underwent a single redo MVR and 12 patients had multiple redo MVRs. Fifty-eight (72.5%) were emergency redo procedures. Prosthetic valve thrombosis was present in 73.8%. Ten patients (15.6%) developed postoperative complications. The median hospital stay and ICU stay were 19 (IQR 12-27.5) days and 4 (IQR 3-7) days, respectively. Two patients died in the postoperative period (3.1%). The mean patient follow-up was 42 months. Three patients died during follow-up.

CONCLUSION

The majority of redo MVR procedures were undertaken as an emergency with valve thrombosis being the most common aetiology. The mortality rate was 3.1% and postoperative complication rate was 15.6%.

摘要

背景

由于华法林控制不佳导致机械二尖瓣血栓形成引起的严重心脏衰竭是南非急诊再次二尖瓣置换术(redo MVR)的主要原因。本研究旨在回顾在南非一家三级中心因二尖瓣功能衰竭而接受 redo MVR 的患者的结局。

方法

对 10 年间(2005-2014 年)接受 redo MVR 的患者进行回顾性病历回顾。分析患者的人口统计学资料、瓣膜功能障碍的病因、术前临床评估和结局。

结果

64 例患者进行了 80 例二尖瓣手术。M:F 比例为 1:2.8,初始手术和 redo 手术时的中位年龄分别为 18(IQR 14-28.5)和 25(IQR 18-40)。 redo MVR 与初始 MVR 之间的中位间隔为 47.5(IQR 7.5-124)个月。58 例患者(90.6%)的原始病变为风湿性瓣膜病。52 例患者进行了单次 redo MVR,12 例患者进行了多次 redo MVR。58 例(72.5%)为急诊 redo 手术。73.8%存在人工瓣膜血栓形成。10 例(15.6%)患者术后发生并发症。中位住院时间和 ICU 住院时间分别为 19(IQR 12-27.5)天和 4(IQR 3-7)天。2 例患者术后死亡(3.1%)。平均患者随访时间为 42 个月。3 例患者在随访期间死亡。

结论

大多数 redo MVR 手术是作为急诊手术进行的,最常见的病因是瓣膜血栓形成。死亡率为 3.1%,术后并发症发生率为 15.6%。

相似文献

1
A South Africa tertiary centre experience with redo mitral valve replacement.南非一家三级医疗中心 redo 二尖瓣置换术的经验。
S Afr J Surg. 2022 Mar;60(1):44-48.
2
Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience.成人患者再次二尖瓣置换术后的结局:一项为期10年的单中心经验。
Interact Cardiovasc Thorac Surg. 2012 May;14(5):575-9. doi: 10.1093/icvts/ivs005. Epub 2012 Jan 31.
3
Redo mitral valve replacement in children.儿童二尖瓣置换术再次手术
Ann Thorac Surg. 2005 Aug;80(2):642-5; discussion 645-6. doi: 10.1016/j.athoracsur.2005.02.052.
4
Reoperative Mitral Surgery Versus Transcatheter Mitral Valve Replacement: A Systematic Review.再次二尖瓣手术与经导管二尖瓣置换术:系统评价。
J Am Heart Assoc. 2021 Mar 16;10(6):e019854. doi: 10.1161/JAHA.120.019854. Epub 2021 Mar 9.
5
Reoperative mitral valve replacement: importance of preservation of the subvalvular apparatus.再次二尖瓣置换术:保留瓣下结构的重要性。
Ann Thorac Surg. 2002 Nov;74(5):1482-7. doi: 10.1016/s0003-4975(02)03950-4.
6
The Cox-Maze III procedure for atrial fibrillation associated with rheumatic mitral valve disease.用于治疗与风湿性二尖瓣疾病相关的心房颤动的Cox迷宫III手术。
Ann Thorac Surg. 1999 Sep;68(3):799-803; discussion 803-4. doi: 10.1016/s0003-4975(99)00777-8.
7
Impact of valve type on outcomes after redo mitral valve replacement in patients aged 50 to 69 years.瓣膜类型对50至69岁患者再次二尖瓣置换术后结局的影响。
Interact Cardiovasc Thorac Surg. 2018 Sep 1;27(3):322-327. doi: 10.1093/icvts/ivy109.
8
Redo mitral valve surgery following prior mitral valve repair.二尖瓣修复术后再次行二尖瓣手术。
J Card Surg. 2018 Dec;33(12):772-777. doi: 10.1111/jocs.13944. Epub 2018 Dec 12.
9
Simple Interrupted Suturing for Redo Mitral Valve Replacement.二尖瓣再次置换术的单纯间断缝合术
J Heart Valve Dis. 2016 Nov;25(6):685-690.
10
Patient-Specific Approach to Mitral Valve Replacement in Infants Weighing 10 kilograms or less.针对体重10公斤及以下婴儿的二尖瓣置换术的个体化治疗方法。
World J Pediatr Congenit Heart Surg. 2019 May;10(3):304-312. doi: 10.1177/2150135119837200.

引用本文的文献

1
Redo surgery outcomes for obstructed replaced valve: a single-center experience.梗阻性人工瓣膜再次手术的结果:单中心经验
Egypt Heart J. 2025 Mar 18;77(1):31. doi: 10.1186/s43044-025-00627-1.
2
Mechanical valve replacement for patients with rheumatic heart disease: the reality of INR control in Africa and beyond.风湿性心脏病患者的机械瓣膜置换术:非洲及其他地区国际标准化比值(INR)控制的实际情况
Front Cardiovasc Med. 2024 Feb 9;11:1347838. doi: 10.3389/fcvm.2024.1347838. eCollection 2024.
3
Development and testing of a transcatheter heart valve with reduced calcification potential.
具有降低钙化潜能的经导管心脏瓣膜的研发与测试。
Front Cardiovasc Med. 2023 Dec 6;10:1270496. doi: 10.3389/fcvm.2023.1270496. eCollection 2023.
4
Transcatheter heart valve interventions for patients with rheumatic heart disease.风湿性心脏病患者的经导管心脏瓣膜介入治疗。
Front Cardiovasc Med. 2023 Sep 13;10:1234165. doi: 10.3389/fcvm.2023.1234165. eCollection 2023.